Literature DB >> 22634496

Gonadotropin signalling in epithelial ovarian cancer.

Inga Mertens-Walker1, Robert C Baxter, Deborah J Marsh.   

Abstract

Ovarian cancer is the most lethal of all gynecologic malignancies, although its aetiology remains poorly understood. A role for the gonadotropins, follicle-stimulating hormone (FSH) and luteinising hormone (LH), has been implicated in a variety of different aspects of ovarian cancer tumorigenesis, including cellular proliferation, migration and invasion. This review focuses on the latest advances in knowledge concerning signalling pathways and functional consequences of gonadotropin action, including changes in protein-, miRNA- and gene expression, in epithelial ovarian cancer cells.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22634496     DOI： 10.1016/j.canlet.2012.05.017

Source DB:  PubMed          Journal:  Cancer Lett        ISSN： 0304-3835            Impact factor:   8.679


  21 in total

1.  Annotation and cluster analysis of long noncoding RNA linked to male sex and estrogen in cancers.

Authors:  Shouping Liu; Weiwei Lai; Ying Shi; Na Liu; Lianlian Ouyang; Ziying Zhang; Ling Chen; Xiang Wang; Banglun Qian; Desheng Xiao; Qin Yan; Ya Cao; Shuang Liu; Yongguang Tao
Journal:  NPJ Precis Oncol       Date:  2020-03-03

2.  Luteinizing hormone inhibits cisplatin-induced apoptosis in human epithelial ovarian cancer cells.

Authors:  Lingfang Xia; Hao Wen; Xiaotian Han; Jia Tang; Yan Huang
Journal:  Oncol Lett       Date:  2016-01-18       Impact factor: 2.967

3.  Luteinizing hormone compromises the in vivo anti-tumor effect of cisplatin on human epithelial ovarian cancer cells.

Authors:  Yan Huang; Yuqi Zhou; Lingfang Xia; Jia Tang; Hao Wen; Meiqin Zhang
Journal:  Oncol Lett       Date:  2017-12-19       Impact factor: 2.967

4.  MicroRNA-200 family governs ovarian inclusion cyst formation and mode of ovarian cancer spread.

Authors:  Pui-Wah Choi; Wai Wing So; Junzheng Yang; Shubai Liu; Ka Kui Tong; Kin Ming Kwan; Jamie S-L Kwok; Stephen K W Tsui; Shu-Kay Ng; Karen H Hales; Dale B Hales; William R Welch; Christopher P Crum; Wing-Ping Fong; Ross S Berkowitz; Shu-Wing Ng
Journal:  Oncogene       Date:  2020-03-25       Impact factor: 9.867

Review 5.  Sexual dimorphism in solid and hematological malignancies.

Authors:  Isabel Ben-Batalla; María Elena Vargas-Delgado; Lara Meier; Sonja Loges
Journal:  Semin Immunopathol       Date:  2018-10-25       Impact factor: 9.623

Review 6.  Sexual dimorphism in cancer.

Authors:  Andrea Clocchiatti; Elisa Cora; Yosra Zhang; G Paolo Dotto
Journal:  Nat Rev Cancer       Date:  2016-04-15       Impact factor: 60.716

7.  Evaluating the ovarian cancer gonadotropin hypothesis: a candidate gene study.

Authors:  Alice W Lee; Jonathan P Tyrer; Jennifer A Doherty; Douglas A Stram; Jolanta Kupryjanczyk; Agnieszka Dansonka-Mieszkowska; Joanna Plisiecka-Halasa; Beata Spiewankiewicz; Emily J Myers; Georgia Chenevix-Trench; Peter A Fasching; Matthias W Beckmann; Arif B Ekici; Alexander Hein; Ignace Vergote; Els Van Nieuwenhuysen; Diether Lambrechts; Kristine G Wicklund; Ursula Eilber; Shan Wang-Gohrke; Jenny Chang-Claude; Anja Rudolph; Lara Sucheston-Campbell; Kunle Odunsi; Kirsten B Moysich; Yurii B Shvetsov; Pamela J Thompson; Marc T Goodman; Lynne R Wilkens; Thilo Dörk; Peter Hillemanns; Matthias Dürst; Ingo B Runnebaum; Natalia Bogdanova; Liisa M Pelttari; Heli Nevanlinna; Arto Leminen; Robert P Edwards; Joseph L Kelley; Philipp Harter; Ira Schwaab; Florian Heitz; Andreas du Bois; Sandra Orsulic; Jenny Lester; Christine Walsh; Beth Y Karlan; Estrid Hogdall; Susanne K Kjaer; Allan Jensen; Robert A Vierkant; Julie M Cunningham; Ellen L Goode; Brooke L Fridley; Melissa C Southey; Graham G Giles; Fiona Bruinsma; Xifeng Wu; Michelle A T Hildebrandt; Karen Lu; Dong Liang; Maria Bisogna; Douglas A Levine; Rachel Palmieri Weber; Joellen M Schildkraut; Edwin S Iversen; Andrew Berchuck; Kathryn L Terry; Daniel W Cramer; Shelley S Tworoger; Elizabeth M Poole; Sara H Olson; Irene Orlow; Elisa V Bandera; Line Bjorge; Ingvild L Tangen; Helga B Salvesen; Camilla Krakstad; Leon F A G Massuger; Lambertus A Kiemeney; Katja K H Aben; Anne M van Altena; Yukie Bean; Tanja Pejovic; Melissa Kellar; Nhu D Le; Linda S Cook; Linda E Kelemen; Angela Brooks-Wilson; Jan Lubinski; Jacek Gronwald; Cezary Cybulski; Anna Jakubowska; Nicolas Wentzensen; Louise A Brinton; Jolanta Lissowska; Hannah Yang; Lotte Nedergaard; Lene Lundvall; Claus Hogdall; Honglin Song; Ian G Campbell; Diana Eccles; Rosalind Glasspool; Nadeem Siddiqui; Karen Carty; James Paul; Iain A McNeish; Weiva Sieh; Valerie McGuire; Joseph H Rothstein; Alice S Whittemore; John R McLaughlin; Harvey A Risch; Catherine M Phelan; Hoda Anton-Culver; Argyrios Ziogas; Usha Menon; Susan J Ramus; Aleksandra Gentry-Maharaj; Patricia Harrington; Malcolm C Pike; Francesmary Modugno; Mary Anne Rossing; Roberta B Ness; Paul D P Pharoah; Daniel O Stram; Anna H Wu; Celeste Leigh Pearce
Journal:  Gynecol Oncol       Date:  2014-12-17       Impact factor: 5.482

Review 8.  Mechanisms of High-Grade Serous Carcinogenesis in the Fallopian Tube and Ovary: Current Hypotheses, Etiologic Factors, and Molecular Alterations.

Authors:  Isao Otsuka
Journal:  Int J Mol Sci       Date:  2021-04-23       Impact factor: 5.923

Review 9.  New Frontier in Glycoprotein Hormones and Their Receptors Structure-Function.

Authors:  Mariusz W Szkudlinski
Journal:  Front Endocrinol (Lausanne)       Date:  2015-10-19       Impact factor: 5.555

10.  Follicle stimulating hormone modulates ovarian stem cells through alternately spliced receptor variant FSH-R3.

Authors:  Hiren Patel; Deepa Bhartiya; Seema Parte; Pranesh Gunjal; Snehal Yedurkar; Mithun Bhatt
Journal:  J Ovarian Res       Date:  2013-07-20       Impact factor: 4.234
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.